Concepedia

A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: sustained efficiency and simplified administration

Artur Katz, Sidnei Epelman, Agnaldo Anelli, Ethel Gorender, Sueli Monterroso da Cruz, Ricardo Manoel de Oliveira, Lourdes A. Marques

Journal of Cancer Research and Clinical Oncology · 1995 · 33 citations · 7 references

DOIFull text

Open access

Concepts

References

7

PREVENTION OF ISOPHOSPHAMIDE-INDUCED UROTHELIAL TOXICITY WITH 2-MERCAPTOETHANE SULPHONATE SODIUM (MESNUM) IN PATIENTS WITH ADVANCED CARCINOMA

B.M. Bryant, H.T. Ford, Michael Jarman et al. · The Lancet · 1980 · 134 citations

, , +4

Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results.

W Scheef, Klein Ho, N Brock et al. · PubMed · 1979 · 119 citations

, , +15

Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention

N Brock, Jörg Pohl, Jurij Stekar · European Journal of Cancer and Clinical Oncology · 1981 · 112 citations

, , +8

Biologic response modifiers in non-Hodgkin's lymphomas.

Teresa Gilewski, Jon Richards · PubMed · 1990 · 67 citations

, , +12

The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy.

G.L. Andriole, John T. Sandlund, J. Miser et al. · Journal of Clinical Oncology · 1987 · 65 citations

, , +9